Insulet
PODD
#1305
Rank
S$22.30 B
Marketcap
S$316.80
Share price
3.44%
Change (1 day)
-16.33%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): S$0.47 Billion

According to Insulet's latest financial reports the company's current earnings are S$2.52 Billion. In 2024 the company made an earning of S$0.43 Billion, an increase over its 2023 earnings that were of S$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.47 B10.44%
2024 S$0.43 B36.76%
2023 S$0.31 B481.9%
2022 S$54.57 M-45.24%
2021 S$99.64 M43.35%
2020 S$69.51 M18.51%
2019 S$58.65 M41.16%
2018 S$41.55 M-711.95%
2017 -S$6.8 Million-56.85%
2016 -S$15.74 Million-79.31%
2015 -S$76.09 Million63.85%
2014 -S$46.44 Million31.04%
2013 -S$35.44 Million-21.96%
2012 -S$45.41 Million
2010 -S$43.31 Million-42.38%
2009 -S$75.17 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$68.18 Million209.75%
2006 -S$22.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.01 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.30 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$8.11 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$28.49 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-S$0.26 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$0.15 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.23 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA